The Cleveland Clinic Foundation

Latest from The Cleveland Clinic Foundation


Sildenafil Shows Potential as Alzheimer Disease Preventive Therapy

July 27, 2021

The therapy, already FDA-approved for individuals with pulmonary artery disease, was significantly associated with reduced likelihood of Alzheimer disease in both the 65-74 year range and those older than 75 years.